2018 annual financial data

China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares 2018 Operating margin

China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares 2018 operating margin…

Direct answer

Operating margin was 23.25%.

Operating income was 1,632,266 USD and net income was 1,187,581 USD.
Operating cash flow was 1,920,161 USD.
Alpha Vantage

Get free China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,019,243 USD
Operating income
1,632,266 USD
Net income
1,187,581 USD
Operating cash flow
1,920,161 USD

Explore related company data

View all 2018 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares financial years